{{Rsnum
|rsid=9878522
|Chromosome=3
|position=165407371
|Orientation=plus
|GMAF=0.2617
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 5.3 | 36.3 | 58.4
| HCB | 5.1 | 47.4 | 47.4
| JPT | 8.8 | 44.2 | 46.9
| YRI | 10.2 | 50.3 | 39.5
| ASW | 12.3 | 36.8 | 50.9
| CHB | 5.1 | 47.4 | 47.4
| CHD | 11.1 | 30.6 | 58.3
| GIH | 6.9 | 35.6 | 57.4
| LWK | 15.5 | 52.7 | 31.8
| MEX | 12.1 | 20.7 | 67.2
| MKK | 12.8 | 38.5 | 48.7
| TSI | 5.9 | 37.3 | 56.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=6E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}